F K Abdallah
University of Nairobi
8 Papers
30 Citations
F K Abdallah is an academic researcher from University of Nairobi. The author has contributed to research in topics: Medicine & Case series. The author has an hindex of 4, co-authored 8 publications. Previous affiliations of F K Abdallah include College of Health Sciences, Bahrain.
Chat about Author
Papers
Risk factors for abandonment of Wilms tumor therapy in Kenya
Jaime Libes,Oliver Oruko,F K Abdallah,Jessie Githanga,James Ndung'u,J. Musimbi,Festus Njuguna,Kirtika Patel,John H. White,Jason R. Axt,James A. O'Neill,Martha J. Shrubsole,Ming Li,Harold N. Lovvorn +13 more
TL;DR: The purpose of this study was to trace patients diagnosed from 2008 to 2011 with Wilms tumor, estimate the survival rate, and identify risk factors for treatment abandonment.
37
Clinical presentation and treatment outcome in children with nephroblastoma in Kenya
F K Abdallah,William Macharia +1 more
TL;DR: Late presentation, poor availability of cytotoxic drugs and frequent treatment interruptions for various reasons have contributed to the poor outcome of nephroblastoma in Kenya.
Association between Socioeconomic and Psychological Experiences of Parents with Children on Leukemia Treatment in Kenyatta National Hospital, Kenya.
TL;DR: Financial challenge is a major cause of psychological distress thus needs for financial support through collaboration with government institutions, for example, NHIF, development agencies, and nongovernment organization who can contribute toward the treatment cost.
13
Quality of-life in male cancer patients at Kenyatta National Hospital, Nairobi.
TL;DR: The issues affecting the quality of life of male cancer patients stated were pain, inability to work, poor coping with cancer and psychological reactions of work retardation, insomnia, weight loss, fatigability and depression.
Single dose filgastrim in cytotoxic-induced neutropaenia in children.
TL;DR: It is suggested that a single dose of filgastrim should be first tried in cytotoxic induced neutropaenia in the paediatric age group without adverse effects on lymphoblastic leukaemia.